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LIST OF ABBREVIATIONS 
Abi –  phage abortive infection  
E. coli –  Escherichia coli 
EDF –  extracellular death factor 
IPTG –  isopropylthio-β-D-galactoside 
ORF –  open reading frame 
PCD  –  programmed cell death 
PSK  –  post-segregational killing 
RBS –  ribosome binding site 
ROS –  reactive oxygen species 
TA  –  toxin-antitoxin 




Free-living bacteria are often exposed to variable environmental conditions that 
require appropriate adaptation strategies to survive in. Besides planktonic 
lifestyle, bacteria often attach to surfaces and form a biofilm, which provides 
better communication and protection against harmful factors such as antibiotics 
and host immune response. It has been proposed that most chronic infections 
are caused by bacteria growing in biofilms. This slime-enclosed bacterial 
community is enriched with specialized cells that have periods of low metabolic 
activity without genetic change and, thus, have both good tolerance against 
bactericidal antibiotics and ability to repopulate after treatment cycles. 
Researchers have long looked for a genetic basis for this type of dormancy. 
Gene expression profiles of these so-called persister-like cells are distinct from 
normally growing bacteria: among others, the genes encoding toxin-antitoxin 
systems are highly upregulated. A toxin-antitoxin (TA) system codes for an 
autotoxic protein that attacks an essential cellular process when its antidote is 
not available. TA systems are thus able to temporarily halt cell growth. 
Therefore, TA pairs have long been considered good candidates to play a key 
role in developing persister phenotypes and their role within bacterial cell 
physiology has been actively studied for over two decades. However, due to the 
redundancy of chromosomal TA loci, their function is often difficult to test and 
validate.  
Elucidating the mechanism and physiological roles that TA systems play in 
persister cells may contribute to the development of a method to treat 
recalcitrant chronic infections. This dissertation has two main objectives. The 
first is to test whether the most highly upregulated genes in persister-like cells 
constitute a new TA system, and the second is to examine the cross-regulation 
between chromosomally encoded TA systems in Escherichia coli.  
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1. REVIEW OF LITERATURE 
1.1. Discovery of toxin-antitoxin systems 
The first toxin-antitoxin (TA) systems were discovered in plasmids (Ogura & 
Hiraga, 1983, Gerdes, et al., 1985) and were shown to stabilize low copy 
plasmids during the segregation of daughter cells. The molecular mechanism for 
the plasmid maintenance system, termed post-segregational killing (PSK) 
(Gerdes, et al., 1986), was solved nearly ten years later (Van Melderen, et al., 
1994). The daughter cells in a growing bacterial population that have not 
inherited a TA system containing plasmid are selectively killed. Because toxin 
is normally inactive and tightly bound to its antitoxin protein, the killing relies 
on the differential stability of toxin and antitoxin. Toxins are more stable to 
proteolysis than antitoxins. Without a copy of the PSK+ plasmid, the unstable 
antitoxin is not produced and the more stable toxin becomes free from the T-A 
complex and poisons the cell (Fig. 1). 
 
 
Figure 1. Toxin-antitoxin (TA) systems increase plasmid maintenance in growing 
bacterial population by post-segregational killing (PSK). Adapted from (Van Melderen 
& Saavedra De Bast, 2009). 
 
Sequencing of prokaryotic genomes (Eubacteria and Archaea) led to the 
discovery of chromosomal TA loci (Masuda, et al., 1993, Gotfredsen & Gerdes, 
1998, Pandey & Gerdes, 2005). Protein sequences of toxins and antitoxins 
belonging to seven known TA families were used in a BLAST search (Pandey 
& Gerdes, 2005). The large-scale search on 126 sequenced prokaryotic 
genomes revealed a high abundance of TA loci in free-living but not in obligate 
host-associated prokaryotes with reduced genome size. Similar results were 
reported two years later, in which more than 500 annotated genomes were 
subjected to a comprehensive TA search tool named RASTA-Bacteria (Sevin & 








tuberculosis and Nitrosomonas europaea, contain more than 50 TA loci, while a 
maximum of 167 were found in Microcystis aeruginosa NIES-843. The vast 
majority of genomes contain less than 30 TA loci. In high TA numbered 
genomes, each TA family is often represented with multiple TA systems with 
the TA content often changing between isolates of the same species. These 
results support the belief that TA loci are frequently acquired by lateral gene 
transfer. Recent comprehensive comparative genomic analyses of TA systems 
provide a list of new putative TA pairs, including also new TA families 
(Makarova, et al., 2009, Fozo, et al., 2010, Leplae, et al., 2011). The popular 
model organism Escherichia coli K12, wherein new TA families and types have 
been mostly characterized, has been found to host nearly 40 TA loci, including 
12 validated Type II systems (see next paragraph for TA classification)  
(Yamaguchi, et al., 2011) (Table 1). 
 
Table 1. Type II toxin-antitoxin systems identified in the chromosome of Escherichia 
coli K12 strain.  





activity of toxin 
chpB ChpBK ChpBI mazEF mRNA cleavage Unknown (Zhang, et al., 2005) 
dinJ-yafQ YafQ DinJ relBE mRNA 
cleavager 
Lon, ClpXP 
(Prysak, et al., 
2009) 




Dalsgaard, et al., 
2010) 
hicBA HicA HicB hicBA mRNA, tmRNA 
cleavage 
Lon 
(Jorgensen, et al., 
2009) 
hipBA HipA HipB hipBA phosphorylates 
EFTu 
Lon 
(Schumacher, et al., 
2009) 
mazEF 
(chpA) MazF MazE mazEF 
mRNA,rRNA 
cleavage 
Lon, ClpAP (Zhang, et al., 2003) 
mqsRA MqsR MqsA relBE mRNA cleavage Lon, ClpXP (Yamaguchi, et al., 
2009) 
prlF-yhaV YhaV PrlF relBE mRNA 
cleavager 
Unknown 
 Schmidt, et al. 
(2007) 
relBE RelE RelB relBE mRNA 
cleavager 
Lon 
(Pedersen, et al., 
2003) 
rnlAB RnlA RnlB rnlAB mRNA cleavage Lon, ClpXP (Koga, et al., 2011) 




Dalsgaard, et al., 
2010) 
yefM-yoeB YoeB YefM relBE mRNA 
cleavager 
Lon 
(Christensen, et al., 
2004) 
r ribosome-dependent mRNA cleavage 
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1.2. Classification of bacterial TA systems 
Toxin-antitoxin systems are classified into five types based on the nature and 
functionality of the antitoxins. Types I and II are well characterized, whereas 
types III–V have only recently been described. While antitoxins can be either 
RNAs or proteins, the toxins are universally proteins in all types and seem to be 
more constrained in their mode of action. 
Type I. Antitoxin is an antisense RNA that controls translation of the toxin 
mRNA by RNA interference (Fig. 2). The toxin-antitoxin RNA duplex is 
degraded by an RNase, most likely by RNase III. Transcription of the toxin 
mRNA is controlled either by weak constitutive promoter (i.e. hok toxins) or by 
SOS responsible LexA repressor (i.e. symE, tisB toxins). Antitoxin is normally 
synthesized constitutively at a high rate, however, it is much less stable 
compared to toxin. Toxins are mostly small hydrophobic proteins with an 
integral membrane domain. Hence, Type I toxins localize in the inner 
membrane resulting in membrane depolarization and permeabilization (Gerdes 
& Wagner, 2007, Fozo, et al., 2010).  
Type II. Toxin and antitoxin are both proteins and encoded by genes of the 
same operon. Antitoxin inhibits toxin by direct protein-protein interaction 
forming a tight complex (Fig. 2). Antitoxin has a DNA binding motif, through 
which it autorepresses transcription of its operon. The toxin-antitoxin complex 
also binds to the promoter region and usually even more avidly than the 
antitoxin alone, causing strong transcriptional repression (see paragraph 1.5). 
Type II toxins most frequently destabilize mRNA by endoribonucleolytic 
cleavage, but some can also attack other targets (see paragraph 1.4). 
Type III. Antitoxin is a small pseudoknot RNA that counteracts the proteic 
toxin by direct RNA–protein interaction (Fig. 2). Pseudoknot is an RNA 
structure that is composed of at least two helical segments connected by single-
stranded regions or loops (Staple & Butcher, 2005). Toxin and antitoxin of 
Type III are transcribed from a single promoter, however, the relative levels of 
toxin and antitoxin synthesis are regulated by a transcriptional terminator 
between the genes (Fineran, et al., 2009). Antitoxins are synthesized from short 
tandem repeats upstream of the toxin gene. Type III ToxN toxin is a sequence-
specific RNAse (structural homolog of Type II MazF/Kid toxin family) that 
cleaves also its own antitoxin precursor mRNA to generate mature 36 
nucleotide long pseudoknot (Blower, et al., 2011, Short, et al., 2013). The first 
Type III system was discovered as a phage protection system encoded by a 
plasmid within the plant pathogen Erwinia carotovora (Fineran, et al., 2009). 
ToxIN TA system functions as an abortive infection (Abi) system which is 
based on “altruistic” suicide of infected bacterium (Chopin, et al., 2005). 
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Figure 2. Regulation of TA systems: Type I–III. Adapted from (Yamaguchi, et al., 
2011). 
 
Type IV. Antitoxin is a protein and protects the target of the toxin from getting 
poisoned (Masuda, et al., 2012). It is a unique example of a putative TA system, 
in which YeeV (CbtA) toxin blocks polymerization of cytoskeletal proteins 
MreB and FtsZ, thereby inhibiting cell division in Escherichia coli (Tan, et al., 
2011). The YeeU (CbeA) antitoxin presumably promotes bundling of linear 
cytoskeleton polymers by interacting directly with MreB and FtsZ. The 
molecular mechanism, of how exactly YeeU antagonizes the activity of YeeV 













Antitoxin protein Toxin protein
mRNA and antisense RNA complex
Growth arrestGrowth
Degradation of RNA complex










Type V. Proteic antitoxin neutralizes its toxin by cleaving its mRNA. In this 
unique TA system, the GhoT (previously YjdO in E. coli K12) toxin is a lytic 
membrane peptide. The formation of ghost cells is counteracted by GhoS (YjdK 
in E. coli K12) antitoxin through sequence-specific cleavage of ghoT mRNA. 
ghoS and ghoT are co-transcribed similarly to Type II systems. However, unlike 
Type II proteic antitoxins, GhoS does not regulate its promoter and is not labile 
(Wang, et al., 2012b). 
 
 
1.3. Main characteristics of Type II toxin-antitoxin systems 
A polypeptide that is a part of a two-component protein complex may become 
toxic when being overexpressed or when its interaction partner is eliminated. 
However, this alone does not show that these two proteins constitute a TA 
system. Therefore, to define a new toxin-antitoxin system the candidates have to 
fulfill several criteria: (1) the system is formed by a pair of adjacent genes that 
encode a relatively stable autotoxic protein (toxin) and its short-lived inhibitor 
(antitoxin), (2) transcription of the TA operon is autorepressed by the antitoxin 
alone or by toxin-antitoxin complex, and (3) the main biological function of the 
toxin must be inhibition of cell growth.  
Some Type II TA systems may have exceptional features. For instance, a 
well characterized Type II TA system, ω-ε-ζ, has a separate transcriptional 
regulator ω as a third component (Zielenkiewicz & Ceglowski, 2005). 
Analogous systems containing additional transcriptional repressor were recently 
found in the ParE family of toxins (Hallez, et al., 2010). The third component 
can also function as a chaperon by preventing rapid degradation or aggregation 
of the antitoxin as was recently described for the higBA locus in Mycobacterium 
tuberculosis (Bordes, et al., 2011).  
 
 
1.4. Enzyme activities of Type II toxins 
Most Type II TA toxins in E. coli K12 act as endoribonucleases, also termed 
mRNA interferases, that cleave mRNA (Table 1). Active mRNA interferases 
drastically increase the number of stalled ribosome-mRNA complexes which 
are rescued by tmRNA (Christensen & Gerdes, 2003, Christensen, et al., 2003). 
Bacterial translation of an mRNA starts before the end of its transcription from 
DNA. If an mRNA is truncated and lacks a stop codon, the ribosome stalls at 
the 3’ end. This happens because the release factors that should terminate 
translation only recognize stop codons (Brown & Tate, 1994). At this point, 
tmRNA enters into the trapped ribosome and mimics tRNA and a piece of 
mRNA that encodes a proteolytic tag (Keiler, et al., 1996). tmRNA with an in 
frame stop codon helps to disassemble the stalled complex, and the faulty 
protein and mRNA are sent to degradation. 
 4
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Some endoribonucleases are sequence specific cutters (ChpBK, MazF, 
MqsR, YafQ), others do not exhibit any sequence specificity (HicA, HigB, 
RelE, YafO, YoeB). Besides, some mRNA interferases (most of the RelE 
family toxins) are ribosome-dependent and cleave only mRNA that is bound to 
the ribosome. The well-studied RelE is mRNA interferase, which cleaves 
mRNA between the second and third nucleotide located in the ribosomal 
acceptor site A (Christensen & Gerdes, 2003, Pedersen, et al., 2003). The well-
known sequence specific MazF and MqsR nucleases are ribosome-independent 
interferases. MazF toxin cleaves single-stranded mRNA at ACA motifs (Zhang, 
et al., 2003) and it also cleaves an ACA sequence near the 3’ end of 16S rRNA. 
By cutting off the anti-Shine-Dalgarno sequence, MazF promotes formation of 
specialized ribosomes that can translate leaderless mRNAs (Vesper, et al., 
2011) and causes significant changes in the protein expression profile (Amitai, 
et al., 2009). VapC, a toxin of the largest TA family, is also a sequence-specific 
RNA interferase. VapC protein contains a metal-binding PIN (PilT N-terminal) 
domain, thus, depending on bacterial species, it is a Mg2+– and/or Mn2+–
dependent endoribonuclease (Clissold & Ponting, 2000, Arcus, et al., 2004, 
Arcus, et al., 2005, Bunker, et al., 2008). The sequence specificity of VapC 
varies between species. For example, in the human pathogen Mycobacterium 
tuberculosis, VapC cuts at GC-rich 4-mers of mRNA, whereas, GG^(U/G)G is 
the optimal target in Pyrobaculum aerophilum (McKenzie, et al., 2012, Sharp, 
et al., 2012). Enteric VapC proteins were shown to specifically cleave initiator 
tRNAfMet between the anticodon stem and loop in vitro and in vivo (Winther & 
Gerdes, 2011), but they do not cut model mRNAs, ribosomal RNAs or other 
tRNAs (Winther & Gerdes, 2009). 
Another observed target of Type II toxins is replication, in which the toxin 
poisons DNA gyrase (topoisomerase II) activity on DNA. DNA gyrase is 
responsible for ATP-dependent negative supercoiling of DNA, which is 
essential for the initiation as well as elongation of DNA replication and general 
transcription (Gellert, et al., 1976, Kreuzer & Cozzarelli, 1979, Nollmann, et 
al., 2007). To maintain the negative supercoiling of DNA, gyrase introduces 
temporal double-strand brakes into the DNA and religates them afterwards. The 
CcdBF toxin encoded by F-plasmid attacks gyrase by forming a trapped ternary 
complex of DNA-Gyrase-CcdBF, in which gyrase cannot religate double-strand 
breaks within the DNA (Bernard, et al., 1993). Subsequent dissociation of the 
complexes by an unknown mechanism results in accumulation of fragmented 
DNA, which is lethal for the cell. The quinolone class of antibacterial drugs 
function by a similar mechanism (Drlica, et al., 2009). 
HipA toxin of the hipBA TA system in E. coli is a protein kinase that 
phosphorylates elongation factor EF-Tu (Schumacher, et al., 2009). EF-Tu 
mediates aminoacyl-tRNA binding to the ribosome. Normally, GTP hydrolysis 
triggers conformational change in EF-Tu, which then dissociates from the 
ribosome for recycling. Phosphorylated Thr382 of the EF-Tu blocks formation of 
GTP-bound closed form of EF-Tu, which cannot bind aminoacyl-tRNA 
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(Lippmann, et al., 1993, Alexander, et al., 1995). Hence, the translation process 
halts due to inactivated EF-Tu. However, these results were obtained from in 
vitro study and should be validated in vivo. 
Zeta toxins of the epsilon/zeta TA systems attack bacterial cell wall 
synthesis. Zeta toxin is a kinase that phosphorylates UDP-N-acetylglucosamine 
(UNAG) using ATP as phosphate donor (Mutschler, et al., 2011). UNAG is an 
essential precursor metobolite required for biosynthesis of pepidoglycan. The 3’ 
hydroxyl group of N-acetyl-glycoseamine, that is the target of zeta toxin, is 
needed for pentapeptide linkage (Barreteau, et al., 2008). Phosphorylation of 
this 3’OH blocks synthesis of peptidoglycan which ultimately leads to cell 
autolysis. In addition, accumulation of UNAG-3P in the cytosol competitively 
inhibits MurA, the enzyme of the first step in synthesis of peptidoglycan 
(Mutschler, et al., 2011). 
 
 
1.5. Regulation of Type II TA Transcription 
In addition to the interaction with its toxin, an antitoxin has a DNA binding 
domain. Through this domain, the antitoxin dimer binds to a palindrome in its 
promoter region and acts as a transcriptional repressor. The binding affinity of 
the antitoxin dimer to DNA is strongly affected (enhanced or inhibited) by the 
toxin. This regulatory property, termed conditional cooperativity, is described in 
different TA families, including, for example, the PhD/Doc (Magnuson & 
Yarmolinsky, 1998), CcdAB (Madl, et al., 2006), and RelBE systems 
(Overgaard, et al., 2008). Stressful conditions activate proteases that degrade 
unstable antitoxins faster than toxins. Hence, the relative amount of cellular 
toxin and antitoxin varies between growth conditions. Depending on the ratio 
between the toxin and the antitoxin, the TA complexes with different 
stoichiometry can be formed. In the RelBE system of E. coli, two complexes 
form: when the concentration of RelB exceeds that of RelE, a RelB2-RelE1 
complex is observed; when the amount of RelE is higher, a RelB2-RelE2 
complex is observed. The first complex (2:1) binds strongly to palindromes in 
the promoter region and represses the trancription, whereas the second (2:2) 
cannot bind to DNA. RelB alone binds to the operator DNA only in vitro with 
weak affinity, therefore, the toxin is required for efficient autorepression 
(Overgaard, et al., 2008). The molecular mechanism of conditional 
cooperativity in the PhD/Doc system was recently solved (Garcia-Pino, et al., 
2010) (Fig. 3). The Doc toxin molecule has actually two binding sites for the 
PhD antitoxin: high (H) and low (L) affinity sites. The H site is conventional 
and the L is the key interaction site allowing Doc to bridge together two PhD 
dimers bound to two successive palindromes. The L site binding only appears in 
a complex wherein at least one of the H affinity sites is unoccupied. However, if 
the amount of Doc toxin exceeds that of PhD, the rigid Doc-PhD2-Doc complex, 
involving only H site of toxin, is formed. As such complex cannot bind to two 
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palindromic operator sites, this results in promoter derepression. Conditional 
cooperativity of RelBE functions in much the same way. Transcription of 
vapBC in Salmonalla enterica is also regulated by conditional cooperativity, 
albeit, with a slighly different mechanism. The bridging of DNA-bound 
antitoxin dimers is mediated by dimerization of two VapC toxins. Excess of 
VapC, however, disrupts the cooperative DNA binding of the [(VapBC)2]2 
complex by breaking the VapC dimers (Winther & Gerdes, 2012). It was 
proposed that all Type II TA systems are regulated by conditional cooperativity. 
However, a recent study states that the transcription of the MqsRA system in E. 
coli is not enhanced by cooperative binding of the MqsR-MqsA complex to its 
operator DNA (Brown, et al., 2013). The DNA and the MqsR toxin binding 
sites on MqsA antitoxin are mutually exclusive as they partially overlap. 
Affinities of the binding sites are also similarly strong. Unlike most antitoxins, 
MqsA is completely structured in a free state while being stabilized by a zinc 
ion (Brown, et al., 2009). Therefore, MqsA alone is an effective repressor. The 
excess of MqsR results destabilization of the MqsA-DNA complex and, as a 
consequence, in derepression of TA operon transcription. 
 
 
Figure 3. Molecular mechanism of conditional cooperativity in transcriptional 




1.6. Physiological roles proposed for chromosomal  
Type II TA systems 
Since the discovery of chromosomally encoded TA loci, the role of these 
poisonous entities play in the cell continues to be debated. Their function in 
plasmids as providers of maintenance is credible for the microbiology 
community (See paragraph 1.1). However, stabilization of plasmid (or any 
mobile genetic element) could be a side effect that results from the properties of 
TA systems: a decay of less stable antitoxin releases active toxin, which in turn 
leads to cell stasis or killing in plasmid-free cells. This view is also supported 
by the fact that plasmids already have much more effective active segregation 
(partition) systems than the proposed TA loci (Vecchiarelli, et al., 2012). In 
addition, some researchers have suggested an existence of excellent symbiosis 
between PSK and partition systems to provide cost-effective maintenance of 
plasmids (Brendler, et al., 2004). Obviously, this role is questionable among 
highly widespread chromosomal TA loci, which suggests a different primary 
function. Therefore, many studies have been performed by disrupting single or 
multiple TA open reading frames to see differences in cell physiology, or by 
examining up- and downregulations of expression of TA systems under various 
stress conditions. 
To date, at least eight different models have been proposed, wherein 
chromosomal Type II TA systems may have a regulatory function. The models, 
described below, are programmed cell death, growth adjustment in stress 
response, development, persistence, phage protection, genome stabilization, 
anti-addiction, and selfish entities. 
Programmed cell death (PCD). This model is based on activation of the 
MazEF TA system in E. coli observed under various stresses uniquely by 
Engelberg-Kulka group (Aizenman, et al., 1996, Sat, et al., 2003, Hazan, et al., 
2004). Bacteriostatic antibiotics were shown to activate MazF toxin in E. coli 
MC4100 (Sat, et al., 2001). Activated MazF was demonstrated to increase the 
level of reactive oxygen species (ROS), probably due to truncated detoxifying 
proteins, which lead to cell death in aerobic but not in anaerobic conditions 
(Kolodkin-Gal, et al., 2008). Deletion of mazEF abolishes rifampicin-induced 
PCD in dense cultures but not at low cell densities (Kolodkin-Gal, et al., 2007). 
That led to discovery of another MazF mediated but ROS-independent death 
pathway, which depends on a cell produced quorum-sensing-like linear 
pentapeptide Asn-Asn-Trp-Asn-Asn, termed as EDF (extracellular death factor) 
(Kolodkin-Gal, et al., 2008). EDF was isolated from the supernatant of an 
exponential phase culture of E. coli MC4100 (Kolodkin-Gal, et al., 2007). 
There is no protein in E. coli that contains this sequence. Therefore, it is not 
exactly known how EDF is generated, however, the authors demonstrate that 
EDF-mediated MazF-dependent killing does not occur in clpP (protease) and 
zwf deficient strains. The gene zwf encodes glucose-6-phosphate-1-dehydro-
genase and contains a sequence (Asn-Asn-Trp-Asp-Asn) that differs by one 
5 
18 
amino acid from the EDF sequence. This led the authors to hypothesize that a 
precursor of EDF may be generated by ClpPX protease during the degradation 
of Zwf, which may be further amidated to the EDF sequence (Kolodkin-Gal, et 
al., 2007, Kolodkin-Gal & Engelberg-Kulka, 2008). Recently, it was reported 
that EDF outcompetes MazE antitoxin from the MazE-MazF complex in vitro 
by directly binding to the MazF. This in turn leads to enhanced RNA cleavage 
(Belitsky, et al., 2011). EDF is supposed to lead to MazF-mediated killing after 
being in a growth arrested state longer than ’the point of no return’ (Amitai, et 
al., 2004). Several groups have tried, but could not reproduce the MazF-
dependent killing (Pedersen, et al., 2002, Tsilibaris, et al., 2007, Fu, et al., 
2009, Christensen-Dalsgaard, et al., 2010). These groups suggest that MazF 
operates like other endoribonucleases in E. coli inducing a state of reversible 
bacteriostasis. Probably, the MazF-dependent killing is a strain- and cell 
density-specific phenomenon, because, for instance, a widely used E. coli 
MG1655 strain does not produce EDF (Kolodkin-Gal & Engelberg-Kulka, 
2008). Recently, novel EDF-like quorum-sensing peptides, which are able to 
induce the MazF-dependent cell death, were isolated from Pseudomonas 
aeruginosa and Bacillus subtilis (Kumar, et al., 2013). Bacterial PCD cannot be 
a reasonable solution for an individual bacterial cell to resist the stress. 
However, a bacterial population that acts like a multi-cellular organism may 
possibly benfit from stress-induced PCD, which provides nutrients and/or 
signals for the suvivors, or protection against phages. 
Growth adjustment in stress response. This model originates from studies of 
the RelBE TA system in E. coli and contrasts to the PCD (Christensen, et al., 
2001). Under normal growth conditions RelB and RelE proteins are in complex 
at a 2:2 ratio (Overgaard, et al., 2008). However, under amino acid starvation, 
stress-induced Lon protease degrades RelB antitoxin, which leads to release of 
RelE toxin and subsequently to growth inhibition. Bacteriostatic properties were 
confirmed on RelE-arrested cells that were able to form colonies after the over-
expression of the antitoxin RelB. The notion, that ectopic production of 
endoribonucleases is bacteriostatic rather than bactericidal, is consistent with 
studies performed by many research groups (see the PCD model section). 
Amino acid starvation induces most of the Type II TA loci in E. coli, which 
rapidly inhibit translation and reset the mRNA pool (Christensen, et al., 2001, 
Christensen, et al., 2003, Jorgensen, et al., 2009, Christensen-Dalsgaard, et al., 
2010). Downregulating the global translation rate is probably beneficial for a 
cell to adapt to the limited supply and to maintain translation accuracy.  
Development. A MazF homolog was reported to cause PCD during fruiting-
body formation in Myxococcus xanthus (Nariya & Inouye, 2008). M. xanthus 
will develop myxospores under nutrient limitation, wherein 80% of the cell 
population undergoes cell lysis (Wireman & Dworkin, 1977). The mazF-mx 
gene was reported to form an unusual TA system with the key developmental 
regulator mrpC, which bears no resemblance to the mazE antitoxin. The 
relevance of MazF-mx in the PCD was discredited by Lee and colleagues (Lee, 
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et al., 2012). The deletion of mazF-mx in two different wild-type M. xanthus 
strains revealed only a marginal decrease of developmental PCD, in contrast to 
the reduction obtained previously from a mutant background strain. Recently, a 
third group demontrated that MrpC actually activates transcription of mazF-mx 
by binding to its promoter in developing cells (Boynton, et al., 2013). There-
fore, MazF-mx probably functions without an antitoxin and is not expressed in 
vegetative cells. The strain, in which MazF-mx-dependent PCD was described, 
has a mutant pilQ (encodes secretin homolog), which increases permeability of 
the outer membrane and, thus, was shown to be highly vulnerable to 
vancomycin drug (Wall, et al., 1999). Introducing the pilQ1 mutation together 
with deletion of the mazF-mx to a wildtype M. xanthus strain generated the 
same phenotype reported by Nariya and Inouye (Boynton, et al., 2013). Hence, 
the MazF-mx involvement in PCD is observed by using pilQ mutant strain. 
Persistence. This model by nature is similar to that of the growth adjustment 
model. Cells that survive bactericidal antibiotics because of dormancy, which 
does not involve genetic resistance mechanisms, are termed persisters (Lewis, 
2007). After antibiotic treatment, persister cells can start growing again. 
Biofilms are enriched for persisters, which might be the major cause of chronic 
infections (Costerton, et al., 1999, del Pozo & Patel, 2007, Mulcahy, et al., 
2010). In planktonic cultures, persister cells form a small fraction that starts to 
increase in late-exponential and stationary phase (Spoering & Lewis, 2001, 
Keren, et al., 2004a). In addition, persister frequency depends on different 
growth conditions, age of the inoculum, and the growth media (Jõers, et al., 
2010, Luidalepp, et al., 2011). Different bactericidal antibiotics also leave a 
different persister fraction (Dorr, et al., 2009, Ankomah, et al., 2013, Kwan, et 
al., 2013). The mechanism behind the formation of these rare cells has remained 
elusive for a long time. However, a recent publication appeared that presents 
compelling evidence for one plausible mechanism for persister generation 
(Maisonneuve, et al., 2013). This study states that the dormancy of some cells 
in exponentially growing culture is caused by stochastic fluctuations in the level 
of (p)ppGpp. High (p)ppGpp concentration trigers polyphosphate mediated 
activation of Lon protease and consequent degradation of unstable antitoxins. A 
mutation that confers a high persistence phenotype (from persister frequency of 
10–6 to 10–2) was identified in the gene of the HipA toxin (hipA7) of Escherichia 
coli (Moyed & Bertrand, 1983). Bactericidal antibiotics and fluorescence-
activated cell sorting (FACS) have been used to isolate cells that have a 
persister-like phenotype. The gene expression profile of non- lysed planktonic 
cells from ampicillin-treated culture as well as non-growing cells of FACS 
analysis revealed up-regulation of several TA systems (Keren, et al., 2004b, 
Shah, et al., 2006). The induced transcription is also an indirect sign of 
activated toxins since the levels of antitoxins, which autorepress the TA 
operons, must be dropped. Active TA toxins cause growth stasis and therefore 
form a strong basis for a persistence model. Single deletion of relE, mazF, yafQ, 
mqsR or yoeB toxin in E. coli K12 treated with ofloxacin did not reduce the 
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persister count, and only stationary phase cells of ∆hipA had an effect in rich 
medium (Keren, et al., 2004b, Shah, et al., 2006). Later, in another E. coli K12 
strain (BW25113) deletion of mqsR decreased the persister level in response to 
ampicillin treatment (Kim & Wood, 2010) but only when the inoculum was 
taken from an aged culture (Luidalepp, et al., 2011). In addition, deletion of the 
yafQ toxin produced a normal biofilm that was about 2400 times more 
susceptible to killing by certain bactericidal antibiotics compared to wild-type 
(Harrison, et al., 2009). Thus, the importance of TA loci in the persistence 
phenotype may become evident under different assay conditions. Recently, it 
was demonstrated that successive deletion of the 10 endoribonucleolytic TA 
loci of E. coli gradually reduced the level of persisters (Maisonneuve, et al., 
2011). Hence, it is necessary to consider redundancy and possible cross-talk 
when we study TA-related phenotypes, because most bacterial genomes contain 
multiple TA loci. Persistence and growth adjustment models are not mutually 
exclusive. However, every toxin-arrested cell may not become a persister, 
because the vast majority of individual nondividing cells never restart growth 
(Roostalu, et al., 2008, Jõers, et al., 2010). 
Phage protection. Phage abortive behaviour of TA systems was first 
described in Type I (RNA antitoxin) system (Pecota & Wood, 1996, Fineran, et 
al., 2009), but was later found also in Type II MazEF (Hazan & Engelberg-
Kulka, 2004) and RlnAB families (Koga, et al., 2011, Otsuka & Yonesaki, 
2012), and in Type III ToxIN system (Fineran, et al., 2009). Phage abortive 
infection (Abi) is based on altruistic cell suicide of infected bacteria, which 
halts phage propagation within a bacterial population (Chopin, et al., 2005). 
Many different Abi systems are described and one of them involves activation 
of TA toxins. Phage infection probably leads to degradation of labile antitoxins 
due to arrested gene expression of the host, thereby releasing toxins that poison 
the cell. Phages have developed their own antitoxins that mimics and replaces 
the cognate labile antitoxin to circumvent the phage abortion (Otsuka & 
Yonesaki, 2012).  
Genome stabilization, anti-addiction or selfish entities. These three models 
are based on the addictive properties of TA loci. The stabilization model argues 
that the main purpose of chromosomal TA systems is to stabilize non-essential 
genome regions; the anti-addiction model theorizes on the possibility that a 
chromosomal TA system prevents PSK induced by a homologous TA module 
of the lost plasmid; and the selfish model suggests no function for TA loci, 
rather they just persist as selfish modules (Gerdes, et al., 2005, Van Melderen & 





1.7. Families of Type II TA systems 
It is reasonable to expect that toxin-antitoxin operons have spread and evolved 
as modular units. Intriguingly, TAs are not conserved as pairs. On the basis of 
primary sequences, toxins and antitoxins unite into families and superfamilies 
of their own. General classification of Type II TA loci is based on the sequence 
similarity of toxin proteins (Gerdes, et al., 2005, Van Melderen & Saavedra De 
Bast, 2009). Toxin-antitoxin database (TADB) was created to organize data 
about predicted and experimentally validated prokaryotic and archeal Type II 
TA loci (Shao, et al., 2011). According to the TADB web-based database 
(http://bioinfo-mml.sjtu.edu.cn/TADB/) there are eleven two-component and 
three three-component TA families classified on the basis of the sequence 
similarity and tertiary structure of toxin proteins. The two-component families 
are ccd, hicBA, hipBA, mazEF, pem, parDE, phd-doc, relBE, vapBC, mosAT, 
and yeeUV, in which pem (parD) should be placed together with mazEF due to 
homology (Masuda, et al., 1993) and yeeUV should be assigned as Type IV 
now (Masuda, et al., 2012). The tree-component families are ω-ε-ζ, pasABC, 
and paaRA-parE. 
Resolved structures reveal the similarity between several toxins with quite 
dissimilar primary sequences; e.g. RelE and YoeB of E. coli share only 13% 
sequence identity, but are structurally similar to each other (Kamada & 
Hanaoka, 2005, Takagi, et al., 2005). RelE also shares a similar β-sheet core 
structure with MqsR, which was placed into a separate toxin family at first 
(Brown, et al., 2009). Based on the tertiary structure, the RelBE superfamily 
currently contains five subfamilies: RelBE, YefM/YoeB, HigBA, MqsRA and 
PrlF-YhaV (http://bioinfo-mml.sjtu.edu.cn/TADB/). 
Toxins of a particular toxin family can be paired with antitoxins representing 
different antitoxin families. That has led to building an alternative, TA domain 
pair-based classification (Makarova, et al., 2009). Authors reported more than 
6000 TA loci in 750 genomes that are organized into 44 TA domain pair 
groupings in TADB v1.1 database (http://bioinfo-mml.sjtu.edu.cn/TADB/ 
browse_domain.php). Most surprisingly, toxins of the RelE-YoeB-like group 
are paired up with cognate antitoxins that belong to at least 4 different families: 
RHH (ribbon-helix-helix; e.g. RelB (Takagi, et al., 2005)), Xre (e.g. HigA 
(Arbing, et al., 2010)), PHD (e.g. YefM (Kamada & Hanaoka, 2005)) and AbrB 
(e.g. PrlF (Coles, et al., 2005)). Folds and primary sequences of these proteins 
are completely different. Despite their general structural diversity, the structural 
homology of the toxin-binding regions of several antitoxins (e.g. RelB and 






1.8. Interplay between Type II TA systems 
The TA domain pair-based classification (Makarova, et al., 2009) raises a 
hypothesis of gene shuffling between a few major classes of toxins and 
antitoxins (Anantharaman & Aravind, 2003). Here, the protein partners are 
stuck with the requirement of a functional and physical interaction in a newly 
assembled TA system. If a protein swaps partners, it will have a propensity to 
interact with several partners (Gophna & Ofran, 2011). The antitoxin must be 
able to control its newly acquired toxin partner from the very moment of 
shuffling; thus, these two proteins must have cross-reacted already before 
swapping. This hypothesis contradicts the key assumption in the field, which 
states that interaction between cognate toxin and antitoxin is exclusively 
specific: “one toxin for one antitoxin” (Gerdes, et al., 2005). The latter notion is 
based on the observation that deletion mutants of the antitoxin genes usually 
cannot be obtained (Fiebig, et al., 2010). Although solitary toxin and antitoxin 
genes have been found in many genomes (Makarova, et al., 2009), expression 
and functionality of these orphan genes has been rarely demonstrated or tested 
(Nariya & Inouye, 2008). 
Possible cross-reactivity between coexisting TA systems, mostly those that 
share relatively high sequence similarity, has been occasionally tested. Some 
authors report positive results (Santos-Sierra, et al., 1997, Santos Sierra, et al., 
1998, Grady & Hayes, 2003, Wilbaux, et al., 2007), while others did not see 
any cross-reaction (Ramage, et al., 2009, Fiebig, et al., 2010). A recent work 
states that at least limited non-cognate TA interactions occur in Mycobacterium 
tuberculosis, because several antitoxins of this organism could interact both 
functionally and physically with non-cognate toxins (Zhu, et al., 2010). 
However, if toxins are expressed from the arabinose-inducible PBAD promoter 
and antitoxins from an IPTG-inducible promoter, as was performed in the study 
of mycobacterial TA systems, it is important to consider that IPTG inhibits PBAD 
directly (Lee, et al., 2007). Therefore, these functional interactions between 
non-cognate TA partners, reported by Zhu and colleagues, may require 
retesting. 
Another type of cross-talk between TA systems could derive from the 
activity of mRNA interferases. There is a possibility that a toxin could 
specifically degrade an mRNA of another TA system. Indeed, it was recently 
reported that MqsR controls the GhoST TA system, which is an unusual TA 
pair (Type V) where the antitoxin neutralizes toxin by cleaving its mRNA 
(Wang, et al., 2012b). MqsR cleaves the 5’ end of ghoST mRNA, specifically 
degrading the antitoxin-encoding part of mRNA (Wang, et al., 2012a). This 
portion of the mRNA contains three GCU sites recognized by active MqsR. The 
3’ portion, which encodes for the GhoT toxin, does not have any GCU 
sequence. Hence, stress-induced MqsR leads to elevated level of ghoT mRNA 
and subsequent production of an active toxin.  
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2. AIMS OF THE STUDY 
Numerous chromosomal toxin-antitoxin loci are activated in dormant 
subpopulation of bacteria that can tolerate bactericidal antibiotics. These 
persister cells are enriched in biofilms that often cause recurrent and chronic 
infections. The broader aim of this study is to elucidate the mechanism for 
simultaneous activation of TA systems, and to test whether they are linked to 
multidrug tolerance and growth heterogeneity due to their inhibitory effect on 
cell growth. 
Specific objectives of this dissertation are: 
 to test if the gene mqsR, that is upregulated in E. coli cells refractory to 
antibiotic treatment, encodes a toxin and is part of a novel TA system 
(Publication I, II) 
 to characterize toxicity, transcription regulation, phyletic distribution and 
involvement in biofilm formation of the novel mqsRA TA system 
(Publication I, II) 
 to examine potential transcriptional cross-talk between different TA 
systems (Publication III) 
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3. RESULTS AND DISCUSSION 
3.1. MqsRA shares properties common  
to canonical TA systems (I, II) 
3.1.1. MqsR toxicity 
Transcription profiles of persister-like dormant cells revealed that, among other 
genes, TA loci were highly induced (Keren, et al., 2004b, Shah, et al., 2006). 
The most upregulated gene on these profiles was B3022 (ygiU E. coli K12, later 
renamed as mqsR (see paragraph 2.3) (Gonzalez Barrios, et al., 2006)). mqsR is 
located next to B3021 (ygiT, renamed mqsA), that was similarly induced. This 
gene pair was predicted to be a TA system due to several intrinsic 
characteristics: a short intergenic region (1 bp between the two genes) suggests 
cotranscription and translational coupling, small size (98 amino acids MqsR and 
131 MqsA), DNA binding fold in MqsA for putative repressor function, and the 
growth-arresting effect of MqsR (Shah, et al., 2006). 
We overexpressed MqsR in E. coli to test its toxicity. It inhibited bacterial 
growth, which was suppressed by production of the MqsA (YgiT) antitoxin (I, 
Fig. 1). MqsR does not kill bacteria, because colony formation ability did not 
decrease after the prolonged expression of the MqsR toxin. Similar resuscitation 
was observed by others, confirming that MqsR causes a temporal growth arrest 
that is reversible by its cognate antitoxin (Christensen-Dalsgaard, et al., 2010). 
Fluorescence microscopy revealed that MqsR-arrested cells were elongated and 
fatter but not filamented (I, Fig. 2). The mechanism behind this phenotype is to 
be elucidated in the future. 
Because the primary sequence of MqsR did not reveal its molecular target, 
we performed pulse-labeling experiments to measure MqsR toxicity on 
macromolecular synthesis in vivo. Induction of MqsR caused rapid inhibition of 
translation, whereas transcription was less affected, and the effect on replication 
was not clearly pronounced (I, Fig. 4). Further testing in an in vitro coupled 
transcription-translation system revealed no inhibition of translation by MqsR 
(I, Fig. 5). Similar contradictory results appeared for the HipA toxin (Korch & 
Hill, 2006), whereas RelE and MazF inhibited translation both in vivo and in 
vitro (Gotfredsen & Gerdes, 1998, Zhang, et al., 2003). Shortly after submission 
of Publication I, two research groups reported, that MqsR toxicity is based on 
ribosome-independent GCU site-specific endoribonucleolytic activity of the 
protein (Yamaguchi, et al., 2009, Christensen-Dalsgaard, et al., 2010). Based on 
the observation that MqsR cleaves mRNA irrespective of translation, it should 
block translation in vitro. However, we ought to interpret our negative results 
with caution because the S30 extract and protein expression system is an 
artificial setup. Either substrate specificity or inactivity of MqsR may play a 
role here. In addition, a fourth group published crystal structures of MqsRA, 
which linked MqsR to the RelE superfamily of toxins and revealed unique 
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properties of MqsA antitoxin (Brown, et al., 2009). Therefore, activation of 
MqsR toxin causes changes in mRNA pool, blocks translation, and leads to 
production of many truncated misfolded proteins. Bacteria have to overcome 
these obstacles to be able to start growing again.  
 
3.1.2. Transcription of mqsRA operon 
According to bioinformatic data, the consecutive mqsR and mqsA genes are 
expected to constitute an operon, which is regulated by binding of the MqsA to 
the promoter region. To confirm this, we performed RNA analysis using the 
northern blot method. We detected two mqsRA-specific transcripts (I, Fig. 3). 
Further mapping of detected mRNAs with DNA oligoprobes complementary to 
different regions nearby the locus validated cotranscription of mqsR and mqsA. 
Both detected transcripts covered the full operon, one extended at the 3’ end 
into the intergenic region. Additionally, we mapped the exact transcription start 
site to 18 bp upstream of the start codon of mqsR using the 5’ RACE method (I, 
Fig. 3). This is the same site reported by dr Gerdes lab, but different from that 
reported by dr Inouye lab, who mapped mRNA 5’ end to 109 bp upstream; both 
groups used the primer extension technique (Yamaguchi, et al., 2009, 
Christensen-Dalsgaard, et al., 2010). To validate autoregulation by MqsA 
antitoxin, we constructed a PmqsRA promoter region fusion to the lacZ reporter. β-
galactosidase assay confirmed strong repression of the promoter when MqsA 
was induced (I, Fig. 3).  
Summing up, the caracteristics of MqsR and MqsA proteins and the operon 
regulation allow us to conclude that MqsRA is a TA system. 
 
 
3.2. Phylogenetic distribution of mqsRA (I, II) 
To study the phylogenetic distribution of mqsRA we searched for genes 
homologous to MqsR in 914 fully sequenced bacterial genomes. A total of 42 
homologs in 40 genomes were found, most of them in Gamma- and 
Betaproteobacteria (I, Fig. 6). Putative MqsR toxins were also found in Alpha- 
and Deltaproteobacteria, in Chlorobi, and in Acidobacteria, whereas we did not 
find any in phyla Firmicutes and Actinobacteria according to our search criteria. 
Independently, a more comprehensive comparative genomic study of Type II 
TA systems was conducted (Makarova, et al., 2009). In this study, another more 
divergent, phylogenetically distinct group (Group 2) of the MqsR family 
emerged. Group 2 is present mostly in Firmicutes and Chlorobi, but also in 
some phages and prophages. However, only one of the toxin active site residues 
(residue Y81 of E. coli MqsR), and none of the antitoxin-interacting residues, is 
conserved in Group 2. This raises the possibility that Group 2 is functionally 
distinct from Group 1 (II, Fig. 6.2). Hence, two splitting groups become visible 
on the phylogenetic tree of MqsR homologs (II, Fig. 6.1). 
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Most MqsR-encoding genomes contain a single mqsR gene, with few 
exceptions where two or three mqsR homologs were found (I, Fig. 6, II) 
(Makarova, et al., 2009). As a general rule, the presence of mqsR genes differs 
among closely related bacteria. For example, only about one-half of the 
sequenced E. coli genomes contain mqsR homolog gene suggesting that this 
gene was acquired recently through lateral gene transfer or lost due to selective 
pressure. As it is typical with TA loci, all the identified genes that code for the 
MqsR toxin homologs were followed by a putative antitoxin gene. Also, as 
usual in TA operons the genes were either overlapping or separated by a couple 
of nucleotides (I, Table S1). Notably, two distinct helix-turn-helix (HTH) 
subfamilies of antitoxins are linked to the MqsR toxins (Makarova, et al., 
2009). In Group I, the HTH motif of MqsA antitoxin contains an extra N-
terminal zinc-finger domain. In the second subfamily, the HTH domain is fused 
to a domain of GepA (genetic element protein A, an uncharacterized phage-
associated protein) family. Thus, MqsRA as well as other Type II toxins and 
antitoxins have probably assembled several times during their evolution 
(Anantharaman & Aravind, 2003, Leplae, et al., 2011). 
 
 
3.3. Effect of MqsRA on biofilm formation (I, II) 
mqsR (motility quorum sensing regulator) was named by a phenotype in which 
disruption of the mqsR reduced autoinducer-2-mediated biofilm growth in E. 
coli (Gonzalez Barrios, et al., 2006). Later, deletion of five chromosomal TA 
loci was reported to decrease biofilm formation, while individual disruptions 
had no effect (Kim, et al., 2009). Therefore, we conducted biofilm 
measurements with deletion mutants of the mqsRA, relBE, and mazEF operons 
in three different E. coli K-12 strains. Our results indicate the complexity of the 
biofilm regulation, because no common pattern appeared in different TA 
deletion strains (I, Fig. 7). Deletion of mqsR alone in BW25113 had no effect on 
biofilm formation in our crystal violet staining assay. However, biofilm 
formation decreased in both HM21ΔmqsRA and BW25113ΔmqsRA (mqsA ≡ 
ygiT). A similar phenotype appeared after deletion of relBE and mazEF loci, 
whereas individual deletion of relE even enhanced biofilm production. The E. 
coli MG1655 strain, for which the biofilm-related phenotype of mqsR was 
originally reported, was a poor biofilm producer in our assay system, and 
ΔmqsRA biofilm formation resembled to that of the wild-type. Partially, these 
results can be explained by different strain backgrounds. MqsR is less toxic in 
MG1655 and BW25113 strains compared to HM21 (I, Fig. 1, S2). Also, we 
were not able to transform HM21ΔmqsRA with the MqsR expression plasmid, 
while it was possible in MG1655 background (Kim, et al., 2010). 
After submission of Publication I, reports about the ability of MqsA 
antitoxin to regulate other promoters than the mqsRA promoter were published 
(Brown, et al., 2009, Kim, et al., 2010). This was the first proof of auxiliary 
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transcriptional regulation conducted by an antitoxin. Whole-transcriptome 
analysis of cells with overexpressed MqsR (Kim, et al., 2010) led to the 
discovery of the mechanism by which MqsRA loci may mediate environmental 
stress response in bacteria through RNA polymerase sigma factor σS (Wang, et 
al., 2011). σS is a key regulator of stress-related genes. It signals a cell to 
modify, among other things, motility, flagella, curli, biofilm production, and 
stationary growth (Battesti, et al., 2011) (II, Fig. 6.4). MqsA was shown to 
specifically bind to palindromic sequences in the promoter region of rpoS, and 
repress its transcription (Wang, et al., 2011). Under stress, activated Lon 
protease degrades MqsA antitoxin, which leads to derepression of σS, ensuing 
increased biofilm production. 
Taking together the results of recent studies: transcription of mqsRA is not 
regulated by conditional cooperativity (Brown, et al., 2013); the transcription of 
rpoS and consequent production of biofilm is repressed by MqsA; translation of 
many genes can be affected by MqsR toxin. These findings suggest a multilevel 
regulation of biofilm production by the MqsRA TA system (II, Fig 6.4). 
However, we still cannot explain why deletion of the mqsRA operon leads to a 
reduction in biofilm formation, while deletion of mqsR toxin alone has no effect 
or even increases production (Kim, et al., 2010). 
 
 
3.4. Uninhibited toxins cross-activate TA systems (I, III) 
Previous array-based gene expression analysis revealed simultaneous up-
regulation of TA loci in an ampicillin tolerant fraction of E. coli cells (Keren, et 
al., 2004b). These results support the hypothesis that a common regulatory 
mechanism exists for the simultaneous induction of different TA systems. 
Therefore we designed experiments to test possible cross-talk between different 
TA loci in E coli. We hypothesized that an activated (uninhibited) toxin can 
induce other toxins. The assumption was supported by the first relevant test, 
wherein we observed that the abundance of mqsR mRNA increased in response 
to activation of HipA toxin (I, Fig. 3). In further experiments, we overexpressed 
several toxins, one at a time, and monitored changes in various TA mRNAs 
using northern hybridization. As a result, we confirmed strong cross-induction 
of TA mRNAs in response to several toxins. Expression of MazF, MqsR, HicA, 
and HipA clearly induced the transcription of the relBEF operon. Expression of 
YafQ did not, at first glance, induce the relBEF mRNA (III, Fig. 1). However, 
considering that the smaller relBEF-specific fragments can be detected, the 
mRNA might be overexpressed, but subsequently degraded after cleavage by 
YafQ. In the reverse experiment, expression of RelE toxin strongly induced 
transcription of the mqsRA, mazEF, dinJ-yafQ, hicAB, yefM-yoeB, and prlF-yhaV 
TA systems (III, Fig. 2). Mostly, hybridization signals from the antitoxin portion 
of the transcripts were weaker regardless of whether the antitoxin was the first or 
the second gene in the operon. These results may reflect better cleavage of the 
antitoxin part and a higher stability of the toxin-encoding region. 
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Others have also noted some examples of transcriptional cross-induction 
between TA systems as well as cross-activation between toxins. Overproduction 
of MqsR induced transcription of relBE and relF (hokD) (Kim, et al., 2010). 
Ectopic expression of VapC toxins originating from Salmonella and Shigella 
activated RNA cleavage by YoeB toxin (Winther & Gerdes, 2009) and 
production of the Doc toxin activated RelE in E. coli (Garcia-Pino, et al., 2008). 
Transcriptional induction of a TA system appears only when the concentration 
of the toxin exceeds that of its antitoxin. Decreased antitoxin levels probably 
lead to activation of toxin. Hence, by detecting transcriptional induction one 
may conclude activation of the toxin. 
To further analyze whether the transcriptional cross-activation is not a mere 
result of artificial overproduction of toxins, we conducted experiments under 
more physiologically relevant conditions. We induced amino acid starvation by 
addition of mupirocin and monitored mqsR and mazF mRNAs in both wild-type 
and relBEF deficient strains. Amino acid starvation has been reported to 
strongly induce relBE (Christensen, et al., 2001) and mazEF (Christensen, et 
al., 2003). We detected RelBE dependent induction of mazEF in response to 
amino acid shortage, whereas mqsRA mRNA (also strongly induced in amino 
acid starvation) was not affected by the deletion of relBE (III, Fig. 3). Hence, 




3.5. Cross-activation is not affected by deletion  
of proteases known to degrade the antitoxins (III) 
Bacteria are frequently faced with nutrient limitation, which is the most 
common stress in nature. Stress response of bacteria involves induction of 
proteases that degrade ribosomal and truncated proteins to supply resources to 
synthesize stress-related genes (Kuroda, et al., 2001, Choy, et al., 2007, Durfee, 
et al., 2008). Previous studies have revealed degradation of unstable antitoxins 
by the stress-induced ATP-dependent proteases Lon and ClpP (Van Melderen, 
et al., 1994, Lehnherr & Yarmolinsky, 1995, Aizenman, et al., 1996, Christen-
sen, et al., 2004, Overgaard, et al., 2009, Christensen-Dalsgaard, et al., 2010, 
Hansen, et al., 2012). Given that antitoxins are transcriptional autorepressors, 
their degradation results in transcriptional burst of TA operons. Considering 
this, we hypothesized that overexpression of a toxin could lead to activation of 
stress-related proteases. Thus, we tested whether proteases, known to degrade 
antitoxins, are the key regulators for transcriptional cross-activation of TA 
operons. However, in deletion mutant strain lacking three major proteases (lon, 
clpPX and hslVU) we still detected strong induction of relBEF mRNA in 
response to overproduced MazF and MqsR toxins (III, Fig. 4). This indicates 
that either other proteases are involved or a protease-independent mechanism is 
responsible for TA operon cross-activation.  
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3.6. Selective mRNA cleavage by toxins as  
a potential mechanism for gene regulation (III) 
In addition to cross-induction of TA transcription we observed extensive 
cleavage of TA mRNAs upon expression of mRNA interferases (III, Fig. 1, 2). 
Surprisingly, the mRNA cleavage pattern revealed the selective stability of in 
vivo cleaved TA mRNAs on northern blots: the toxin portion of the mRNAs 
accumulated, whereas the antitoxin portion, as well as control mRNAs, almost 
fully degraded (III, Fig. 1, 2, S2). To further characterize the in vivo cleavage of 
relBEF mRNA, we mapped the 5’ ends of the cleavage products generated by 
different toxins using primer extension analysis (III, Fig. 5, S4, Table S3). We 
detected MqsR and HicA cutting sites all over the mRNA and did not see 
selective cleavage on the RelB encoding portion. MazF cutting was more 
clustered, probably because some ACA sites were masked by the mRNA 
secondary structures. Also RelE cleaved its own mRNA. Different primers were 
required to map the full mRNA. Therefore, cleavage efficiency of different 
regions can neither be estimated nor compared.  
We detected mostly cleavage by the overexpressed toxins, because mRNA 
was cut at the sites that are unique for particular toxins. We detected few sites in 
the relBEF mRNA that were cut in response to production of several toxins. We 
wanted to determine whether these sites are a result of cutting by over-
expressed toxin itself or by cross-activated toxins. We tested three of the 
sequence-specific cutting sites (ACA for MazF, GCU for MqsR) to detect 
possible cross-activation in response to expression of HicA. These stops were 
still detected in mazF and mqsR deficient strains suggesting that the cleavage 
was conducted by the HicA itself or by another activated RNase. MazF has a 
homolog ChpB in E. coli that may be involved in the ACA cutting (Zhang, et 
al., 2005). 
Our MazF over-expression resulted in truncated relBEF mRNAs that lack 
ribosome recruitment signals (RBS), but leave the open reading frames (ORF) 
intact. Leaderless mRNAs generated by MazF have been demonstrated before 
(Vesper, et al., 2011). Some mRNAs have ACA sequences in front of AUG 
start codons that can be cleaved by MazF. Furthermore, the authors showed that 
MazF cuts off the anti-Shine-Dalgarno sequence at 3’ end of the 16S rRNA. 
The cleaved 16S rRNA can assemble into specialized ribosome that can 
selectively translate the set of leaderless mRNAs. Hence, activation of MazF 
affects significantly composition of the proteome (Amitai, et al., 2009). To test 
whether RelE protein can be translated from our MazF-cleaved leaderless 
relBEF fragments, we constructed two T7 expression plasmids. One transcript 
started next to the RelB start codon and contained intact RelB-RelE ORFs. The 
other transcript started in the middle of RelB ORF. For RelE detection on 
western blot, the RelE encoding gene was C-terminally His6-tagged and 
mutated to reduce its toxicity. We expressed both of the leaderless relBEF 
mRNAs and demonstrated translation of RelE toxin from the transcripts in vivo 
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(III, Fig. 6). However, the truncated leaderless mRNAs were translated less 
efficiently compared to the full-length mRNA with intact RBS. Thus, activation 
of MazF may lead to translation of leaderless relBEF transcripts resulting in 
unequal production of RelB and RelE proteins, biased towards RelE. 
Increase of the T/A ratio may possibly trigger a positive feedback loop 
consisting of transcriptional activation of the TA operon, successive cleavage of 
the TA transcript, buildup of the toxin-encoding mRNA fragments, and 
translation of them, shifting the T/A balance in favour of toxin (III, Fig. 7). 
Thus, it can be related to TA-linked growth heterogeneity in bacterial 
populations and persister formation that is not dependent on activation of the 
Lon protease (III, Fig. S6) (Keren, et al., 2004b, Shah, et al., 2006, Rotem, et 
al., 2010, Maisonneuve, et al., 2013). 
31 
CONCLUSIONS 
 mqsR and mqsA genes of Escherichia coli encode a toxin-antitoxin system, 
in which MqsR arrests cell growth by blocking translation and MqsA 
counteracts its toxicity. 
 mqsRA constitute an autoregulatory operon, in which trancription is 
repressed by MqsA antitoxin. 
 Although mqsRA homologs are common in gamma- and betaproteobacteria, 
not all closely related bacteria contain this TA operon. 
 MqsRA play a role in the multi-level regulation of biofilm production. 
 Uninhibited toxins cross-activate transcription of TA systems in Escherichia 
coli by an unknown mechanism. 
 Cross-activation is not dependent on Lon and ClpXP proteases known to 
degrade antitoxins. 
 Specific cross-activation between RelBE and MazEF TA systems is detected 
in nutrient limited stress. 
 Toxins with mRNase activity cleave TA mRNA-s in vivo. 
 Accumulation of cleaved transcripts that retain toxin-encoding part may 
serve as an additional source for toxin production. 
 Selective mRNA cleavage by toxins could function as part of a potential 
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SUMMARY IN ESTONIAN 
Bakterite toksiin-antitoksiin süsteemid: transkriptsiooniline 
rist-aktivatsioon ja uue mqsRA süsteemi iseloomustamine 
Looduslikus keskkonnas peavad bakterid populatsiooni säilimiseks kohanema 
muutuvate keskkonnatingimustega. Seejuures on mitmed bakteriliigid, ka pato-
geensed, võimelised kinnituma pindadele ning moodustama biokilet. See 
limane, polüsahhariidse maatriksiga ümbritsetud bakterite kogukond on pare-
mini vastupidav halbadele mõjuritele, nagu näiteks antibiootikumid või pere-
mehe immuunsüsteem. Biokiled arvatakse põhjustavat suuremat osa inimese 
kroonilistest bakterinakkustest. Biokiledes elavate bakterite füsioloogia uuri-
misel on tuvastatud erineva metaboolse aktiivsusega bakterirakke. Võrreldes 
vabalt elavate bakteritega on biokiledes suurenenud ajutiselt mittejagunevate 
bakterite hulk, kelle genoom on identne kasvavate rakkude omaga, kuid kes 
oma uinunud oleku tõttu on surmavatele antibiootikumidele tundetumad. Selli-
seid rakke on hakatud kutsuma persistoriteks ning nad on võimelised anti-
biootikumiravi järgselt taastama populatsiooni arvukuse. Persistorrakkude 
geenide avaldumine on märgatavalt teistsugune võrreldes kasvavate rakkudega: 
muu hulgas on neil tugevalt indutseeritud toksiin-antioksiin (TA) süsteeme 
kodeerivad geenid. TA süsteemis on toksiiniks stabiilne autotoksiline valk, 
mille märklauaks on mõni oluline rakuline protsess. Enamus Escherichia coli II 
tüüpi TA toksiine lõikavad mRNA-d, seega häirivad tugevalt tranlatsiooni ning 
põhjustavad pöörduvat kasvuinhibitsiooni. Normaalselt jagunevates rakkudes 
neutraliseerib ebastabiilne antitoksiin toksiini mõju. II tüüpi TA süsteemides on 
antitoksiiniks valk, mis seondub otse toksiiniga. Kuna E. coli genoomis on 
mitmeid TA süsteeme kodeerivaid geene, siis võiks toksiinide üheaegse akti-
veerumisega selgitada persistorite tekkemehhanismi. Sarnaselt TA süsteemide 
ekspressioonile on antibiootikumide toimele tundetutes rakkudes tugevasti üles 
reguleeritud ka genoomis kõrvuti paiknevad mqsA ja mqsR geenid, mis sarna-
nevad oma suuruse ja organiseerituse poolest tuntud toksiinide geenidega. 
Käesoleva töö üheks põhieesmärgiks oli testida, kas Escherichia coli mqsA 
ja mqsR geenid moodustavad uue TA süsteemi. Katsetulemused näitasid, et 
MqsR üle-ekspressioon põhjustab ajutise rakkude kasvu peatumise, mis on 
pöörduv MqsA valgu juuresolekul. MqsR aktiveerumine põhjustab rakkude 
väliskuju pikenemise ja paksenemise. Kõik seni kirjeldatud II tüüpi TA 
süsteemide geenid paiknevad järjestikku ning moodustavad ühiselt antitoksiini 
poolt negatiivselt reguleeritud operoni. TA operonilt sünteesitakse ühine 
mRNA, millel on enamasti üks ribosoomi seondumiskoht esimese geeni ees. 
Transkriptsiooni analüüs tuvastastas mqsR ja mqsA geenide kuulumise ühisesse 
operoni, mille ekspressiooni represseerib MqsA antitoksiin. Näidati, et MqsR 
inhibeerib tugevalt translatsiooni, kuigi täpset märklauda tuvastada ei õnnes-
tunud. Teiste töögruppide samaaegsed uurimused näitasid, et MqsR toksiin 
lõikab mRNA-d ja et tema tertsiaarstruktuur sarnaneb enim uuritud RelE 
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toksiini superperekonnaga. mqsRA fülogeneesi bioinformaatilisel analüüsil 
täheldati alati kahe geeni koosesinemist, kuid lähedastes liikides ei olnud 
mqsRA alati esindatud. Seega võiks mqsRA levida edukalt horisontaalse geeni-
ülekande kaudu. Katsed mqsRA geenide deletsiooni mõjust erinevate bakteri-
tüvede biofilmi moodustumisele andsid vastakaid tulemusi. Hiljem selgus teiste 
gruppide uurimustest, et MqsA antitoksiinil on võime seonduda ka teistele 
promootor-järjestustele peale enda oma ning represseerida nende geenide 
avaldumist. Muu hulgas inhibeerib MqsA RNA polümeraasi sigma faktori σS 
transkriptsiooni ning seeläbi osaleb ta laialdases stressivastuse regulatsioonis, 
k.a. biofilmi moodustumisel. Kokkuvõtvalt, MqsRA kirjeldati kui uut TA 
süsteemi, millel on uudsed regulatoorsed funktsioonid. 
Töö teine põhieesmärk oli uurida võimalike rist-regulatsioonide esinemist 
Escherichia coli kromosomaalsete II tüüpi TA süsteemide vahel. MazF, MqsR, 
HicA ja HipA toksiinide üle-ekspresseerimine indutseeris tugevalt relBE TA 
süsteemi mRNA sünteesi. Sama täheldati ka vastupidises ekperimendis, kus 
RelE toksiini üle-ekspressioon aktiveeris mitmete TA lookuste ekspressiooni. 
Füsioloogiliste tingimuste matkimiseks tekitati aminohappenälg metsiktüüpi ja 
relBEF mutantses (deletsioon) tüves ning jälgiti mqsRA ja mazEF operonide 
ekspressiooni tugevust mRNA-de hübridisatsioonil. Varasemalt oli teada, et 
aminohappenälg indutseerib tugevalt TA süsteemide transkriptsiooni. Avastati, 
et mazEF transkriptsioon aktiveerus vastusena aminohappenäljale ainult metsik-
tüüpi bakterites kuid mitte relBE defektses tüves. mqsRA transkriptsioon oli 
aktiveeritud mõlemas tüves. Seega võib järeldada, et aminohappenälja korral 
aktiveeritakse mazEF transkriptsioon ainult RelE toksiinist sõltuvalt, mis on 
tõestus spetsiifilisest rist-aktivatsioonist. TA süsteemide transkriptsiooni regu-
latsiooni arvesse võttes võib TA operoni transkriptsiooni aktiveerumisest 
järeldada toksiini kontsentratsiooni ülekaalu võrreldes antitoksiiniga, seega ka 
toksiini aktiveerumist. 
Stressitingimustes lagundab ebastabiilsed antitoksiinid peamiselt Lon 
proteaas, mistõttu stabiilsed toksiinid vabanevad ja ka TA operonide transkript-
sioon derepresseeritakse. Ühe mRNAd lõikava toksiini ekspressioon võib 
aktiveerida Lon sünteesi ning seeläbi aktiveerida ka teised TA süsteemid. Selle 
levinud hüpoteesi testimiseks mõõdeti TA transkriptsiooni rist-aktivatsiooni 
Lon, ClpXP ja HslVU proteaaside defektsetes tüvedes. Vastusena MazF ja 
MqsR ekspressioonile täheldati metsiktüübile sarnane tugev relBEF mRNA 
sünteesi induktsioon. Sellest järeldati, et TA süsteemide transkriptsiooniline 
ristaktivatsioon ei sõltu antud katsetingimustes proteaaside olemasolust. 
Lisaks tugevale rist-aktivatsioonile täheldati toksiinide ekspresseerimisel TA 
mRNA-de valikulist lõikamist. TA mRNA toksiini kodeerivad lõikefragmendid 
akumuleerusid, samal ajal kui antitoksiini kodeerivad mRNA osad efektiivselt 
lagundati. relBE mRNA lõikekohtade täpne määramine tuvastas nn leaderless 
mRNA tekke vastusena MazF toksiini üle-ekspressioonile. Varem on kirjel-
datud translatsiooni toimumist ka sellistelt mRNA-delt, millel puudub ribo-
soomi poolt ära tuntav seondumisjärjestus (Shine-Dalgarno), kuid avatud 
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lugemisraam on terve. Analoogse kärbitud relBE mRNA ekspresseerimisel 
plasmiidilt näidati RelE toksiini translatsiooni in vivo. Seega võib suurenenud 
toksiini kontsentratsioon vallandada rakkudes positiivse tagasiside tsükli, mis 
läbi teiste TA mRNA-de lõikamise ning transleerimise muudab ka toksiinide ja 
antitoksiinide kontsentratsioonide suhet rakus. Sellise potentsiaalse geeni-
regulatsiooni mehhanismi tõendamine toetaks täiendavalt, sõltumata proteaaside 
aktiivsusest, TA süsteemide samaaegse aktivatsiooni teket ning seeläbi selgitaks 
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